Skip to main content
CTMX logo

CTMX · CytomX Therapeutics, Inc. · Analyst Estimates

Track CTMX — free
$2.72 -0.03 (-1.09%) At close · Sep 30
Market Cap
$598.13M
Shares
217.90M
Volume · Sep 30 3.22M Avg daily vol (3M) 3.49M

Analyst Estimates

Compare analyst forecasts for CytomX Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-24 11:34 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.52
-0.39019
-0.28
—
-0.39019
-0.42084
-0.39019
-0.42084
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
1
1
4
3
Revenue
USD
Publication date not stated
10258000
25030930
53700000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.6736
-0.47309
-0.158
—
-0.47309
-0.48566
-0.47309
-0.48566
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
3
2
4
4
Revenue
USD
Publication date not stated
0
25340530
84700000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.11
-0.07076
0.03
—
-0.07076
-0.10517
-0.07076
-0.10517
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
1
1
4
3
Revenue
USD
Publication date not stated
2000000
10450000
37000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.13
-0.10297
-0.056
—
-0.10297
-0.11028
-0.10297
-0.11028
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
3
3
3
2
Revenue
USD
Publication date not stated
2000000
5333330
10000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —
Key facts CIK 1501989 CUSIP 23284F105 13F (30d) 3 filings 3 filers Visit website Investor relations